# QXO, Inc.: financial statements, quarterly

QXO · NYSE · CIK 1236275 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/qxo.md) · [Financials](/companies/qxo/financials.md) · [Filings](/companies/qxo/filings.md) · [Insiders](/companies/qxo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/qxo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [13.4](/filings/0001628280-24-047429.md) | [14.7 d](/filings/0001628280-25-009626.md) | [14.4](/filings/0001628280-25-023834.md) | [14.5](/filings/0001628280-25-040367.md) | [13.1](/filings/0001628280-25-050298.md) | [14.8 d](/filings/0001628280-26-012601.md) | [13.5](/filings/0001628280-26-034130.md) | [1,906](/filings/0001628280-26-056919.md) | [2,728](/filings/0001628280-25-050298.md) | [2,194 d](/filings/0001628280-26-012601.md) | [1,730](/filings/0001628280-26-034130.md) | [3,246](/filings/0001628280-26-056919.md) |
| Cost of revenue | $m | [8.1](/filings/0001628280-24-047429.md) | [9.0 d](/filings/0001628280-25-009626.md) | [8.8](/filings/0001628280-25-023834.md) | [8.7](/filings/0001628280-24-037059.md) | [7.7](/filings/0001628280-24-047429.md) | [8.7 d](/filings/0001628280-25-009626.md) | [8.1](/filings/0001628280-25-023834.md) | [1,505](/filings/0001628280-26-056919.md) | [2,093](/filings/0001628280-25-050298.md) | [1,664 d](/filings/0001628280-26-012601.md) | [1,321](/filings/0001628280-26-034130.md) | [2,443](/filings/0001628280-26-056919.md) |
| Gross profit | $m | [5.4](/filings/0001185185-23-001183.md) | [5.7 d](/filings/0001185185-24-000237.md) | [5.7](/filings/0001185185-24-000475.md) | [5.8](/filings/0001628280-25-040367.md) | [5.5](/filings/0001628280-25-050298.md) | [6.1 d](/filings/0001628280-26-012601.md) | [5.4](/filings/0001628280-26-034130.md) | [401](/filings/0001628280-26-056919.md) | [636](/filings/0001628280-25-050298.md) | [530 d](/filings/0001628280-26-012601.md) | [409](/filings/0001628280-26-034130.md) | [803](/filings/0001628280-26-056919.md) |
| Selling, general and administrative | $m | [7.7](/filings/0001628280-24-047429.md) | [5.1 d](/filings/0001628280-25-009626.md) | [5.2](/filings/0001628280-25-023834.md) | [9.8](/filings/0001628280-25-040367.md) | [39.0](/filings/0001628280-25-050298.md) | [39.0 d](/filings/0001628280-26-012601.md) | [44.4](/filings/0001628280-26-034130.md) | [457](/filings/0001628280-26-056919.md) | [453](/filings/0001628280-25-050298.md) | [441 d](/filings/0001628280-26-012601.md) | [497](/filings/0001628280-26-034130.md) | [649](/filings/0001628280-26-056919.md) |
| Operating income | $m | [(2.6)](/filings/0001628280-24-047429.md) | [0.4 d](/filings/0001628280-25-009626.md) | [0.2](/filings/0001628280-25-023834.md) | [(4.3)](/filings/0001628280-25-040367.md) | [(33.7)](/filings/0001628280-25-050298.md) | [(33.2) d](/filings/0001628280-26-012601.md) | [(39.3)](/filings/0001628280-26-034130.md) | [(163)](/filings/0001628280-26-056919.md) | [25.8](/filings/0001628280-25-050298.md) | [(69.5) d](/filings/0001628280-26-012601.md) | [(252)](/filings/0001628280-26-034130.md) | [(42.0)](/filings/0001628280-26-056919.md) |
| Interest expense | $m | [0.0](/filings/0001185185-23-001183.md) | [0.0 d](/filings/0001185185-24-000237.md) | [0.0](/filings/0001185185-24-000475.md) | [0.0](/filings/0001628280-25-040367.md) | [0.0](/filings/0001628280-25-050298.md) | [0.0 d](/filings/0001628280-26-012601.md) | [0.0](/filings/0001628280-26-034130.md) | [52.0](/filings/0001628280-26-056919.md) | [62.3](/filings/0001628280-25-050298.md) | [58.7 d](/filings/0001628280-26-012601.md) | [56.5](/filings/0001628280-26-034130.md) | [65.0](/filings/0001628280-26-056919.md) |
| Income tax | $m | [(0.5)](/filings/0001628280-24-047429.md) | [(0.0) d](/filings/0001628280-25-009626.md) | [0.1](/filings/0001628280-25-023834.md) | [(0.2)](/filings/0001628280-25-040367.md) | [6.1](/filings/0001628280-25-050298.md) | [16.9 d](/filings/0001628280-26-012601.md) | [8.5](/filings/0001628280-26-034130.md) | [(178)](/filings/0001628280-26-056919.md) | [129](/filings/0001628280-25-050298.md) | [(17.3) d](/filings/0001628280-26-012601.md) | [(53.2)](/filings/0001628280-26-034130.md) | [(22.0)](/filings/0001628280-26-056919.md) |
| Net income | $m | [(2.1)](/filings/0001628280-24-047429.md) | [0.4 d](/filings/0001628280-25-009626.md) | [0.1](/filings/0001628280-25-023834.md) | [(0.6)](/filings/0001628280-25-040367.md) | [17.2](/filings/0001628280-25-050298.md) | [11.3 d](/filings/0001628280-26-012601.md) | [8.8](/filings/0001628280-26-034130.md) | [(59.0)](/filings/0001628280-26-056919.md) | [(139)](/filings/0001628280-25-050298.md) | [(90.2) d](/filings/0001628280-26-012601.md) | [(227)](/filings/0001628280-26-034130.md) | [(55.0)](/filings/0001628280-26-056919.md) |
| Diluted EPS | $ per share | [(3.21)](/filings/0001628280-24-047429.md) | not reported | [0.21](/filings/0001628280-25-023834.md) | [(9.93)](/filings/0001628280-25-040367.md) | [(0.01)](/filings/0001628280-25-050298.md) | not reported | [(0.03)](/filings/0001628280-26-034130.md) | [(0.15)](/filings/0001628280-26-056919.md) | [(0.24)](/filings/0001628280-25-050298.md) | not reported | [(0.35)](/filings/0001628280-26-034130.md) | [(0.14)](/filings/0001628280-26-056919.md) |
| Basic EPS | $ per share | [(3.21)](/filings/0001628280-24-047429.md) | not reported | [0.21](/filings/0001628280-25-023834.md) | [(9.93)](/filings/0001628280-25-040367.md) | [(0.01)](/filings/0001628280-25-050298.md) | not reported | [(0.03)](/filings/0001628280-26-034130.md) | [(0.15)](/filings/0001628280-26-056919.md) | [(0.24)](/filings/0001628280-25-050298.md) | not reported | [(0.35)](/filings/0001628280-26-034130.md) | [(0.14)](/filings/0001628280-26-056919.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue, us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.0](/filings/0001185185-23-001183.md) | [0.0](/filings/0001628280-25-009626.md) | [0.0](/filings/0001185185-24-000475.md) | [1.0](/filings/0001628280-24-037059.md) | [5.0](/filings/0001628280-24-047429.md) | [5.1](/filings/0001628280-26-012601.md) | [5.1](/filings/0001628280-25-023834.md) | [2.3](/filings/0001628280-25-040367.md) | [2.3](/filings/0001628280-25-050298.md) | [2.4](/filings/0001628280-26-056919.md) | [3.0](/filings/0001628280-26-034130.md) | [2.8](/filings/0001628280-26-056919.md) |
| Current assets | $bn | [0.0](/filings/0001185185-23-001183.md) | [0.0](/filings/0001628280-25-009626.md) | [0.0](/filings/0001185185-24-000475.md) | [1.0](/filings/0001628280-24-037059.md) | [5.1](/filings/0001628280-24-047429.md) | [5.1](/filings/0001628280-26-012601.md) | [5.1](/filings/0001628280-25-023834.md) | [6.5](/filings/0001628280-25-040367.md) | [6.2](/filings/0001628280-25-050298.md) | [5.5](/filings/0001628280-26-056919.md) | [6.5](/filings/0001628280-26-034130.md) | [10.3](/filings/0001628280-26-056919.md) |
| Total assets | $bn | [0.0](/filings/0001185185-23-001183.md) | [0.0](/filings/0001628280-25-009626.md) | [0.0](/filings/0001185185-24-000475.md) | [1.0](/filings/0001628280-24-037059.md) | [5.1](/filings/0001628280-24-047429.md) | [5.1](/filings/0001628280-26-012601.md) | [5.1](/filings/0001628280-25-023834.md) | [17.1](/filings/0001628280-25-040367.md) | [16.6](/filings/0001628280-25-050298.md) | [15.9](/filings/0001628280-26-056919.md) | [16.7](/filings/0001628280-26-034130.md) | [22.7](/filings/0001628280-26-056919.md) |
| Current liabilities | $bn | [0.0](/filings/0001185185-23-001183.md) | [0.0](/filings/0001628280-25-009626.md) | [0.0](/filings/0001185185-24-000475.md) | [0.0](/filings/0001628280-24-037059.md) | [0.0](/filings/0001628280-24-047429.md) | [0.0](/filings/0001628280-26-012601.md) | [0.1](/filings/0001628280-25-023834.md) | [2.2](/filings/0001628280-25-040367.md) | [2.0](/filings/0001628280-25-050298.md) | [1.6](/filings/0001628280-26-056919.md) | [1.9](/filings/0001628280-26-034130.md) | [2.5](/filings/0001628280-26-056919.md) |
| Total liabilities | $bn | [0.0](/filings/0001185185-23-001183.md) | [0.0](/filings/0001628280-25-009626.md) | [0.0](/filings/0001185185-24-000475.md) | [0.0](/filings/0001628280-24-037059.md) | [0.0](/filings/0001628280-24-047429.md) | [0.0](/filings/0001628280-26-012601.md) | [0.1](/filings/0001628280-25-023834.md) | [7.2](/filings/0001628280-25-040367.md) | [6.8](/filings/0001628280-25-050298.md) | [6.2](/filings/0001628280-26-056919.md) | [6.5](/filings/0001628280-26-034130.md) | [10.3](/filings/0001628280-26-056919.md) |
| Long-term debt | $bn | [0.0](/filings/0001185185-23-001183.md) | [0.0](/filings/0001628280-25-009626.md) | [0.0](/filings/0001185185-24-000475.md) | [0.0](/filings/0001628280-24-037059.md) | [0.0](/filings/0001628280-24-047429.md) | [0.0](/filings/0001628280-26-012601.md) | not reported | [3.1](/filings/0001628280-25-040367.md) | [3.1](/filings/0001628280-25-050298.md) | [3.1](/filings/0001628280-26-056919.md) | [3.1](/filings/0001628280-26-034130.md) | [6.0](/filings/0001628280-26-056919.md) |
| Current portion of debt | $bn | [0.0](/filings/0001185185-23-001183.md) | [0.0](/filings/0001628280-25-009626.md) | [0.0](/filings/0001185185-24-000475.md) | [0.0](/filings/0001628280-24-037059.md) | [0.0](/filings/0001628280-24-047429.md) | [0.0](/filings/0001628280-25-023834.md) | [0.0](/filings/0001628280-25-023834.md) | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [0.0](/filings/0001628280-24-047429.md) | [0.0](/filings/0001628280-26-012601.md) | [0.0](/filings/0001628280-25-040367.md) | [1.0](/filings/0001628280-25-050298.md) | [5.0](/filings/0001628280-25-050298.md) | [5.1](/filings/0001628280-26-056919.md) | [5.1](/filings/0001628280-26-056919.md) | [9.9](/filings/0001628280-26-056919.md) | [9.8](/filings/0001628280-25-050298.md) | [9.7](/filings/0001628280-26-056919.md) | [10.2](/filings/0001628280-26-056919.md) | [10.4](/filings/0001628280-26-056919.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1.1 d](/filings/0001628280-24-047429.md) | [(0.2) d](/filings/0001628280-25-009626.md) | [0.4](/filings/0001628280-25-023834.md) | [(1.1) d](/filings/0001628280-25-040367.md) | [31.6 d](/filings/0001628280-25-050298.md) | [53.9 d](/filings/0001628280-26-012601.md) | [36.5](/filings/0001628280-26-034130.md) | [(175) d](/filings/0001628280-26-056919.md) | [213 d](/filings/0001628280-25-050298.md) | [187 d](/filings/0001628280-26-012601.md) | [70.6](/filings/0001628280-26-034130.md) | [(217) d](/filings/0001628280-26-056919.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001628280-24-047429.md) | [0.0 d](/filings/0001628280-25-009626.md) | [0.1](/filings/0001628280-25-023834.md) | [0.0 d](/filings/0001628280-24-037059.md) | [0.0 d](/filings/0001628280-24-047429.md) | [0.0 d](/filings/0001628280-25-009626.md) | [0.1](/filings/0001628280-25-023834.md) | [19.9 d](/filings/0001628280-26-056919.md) | [29.8 d](/filings/0001628280-25-050298.md) | [28.4 d](/filings/0001628280-26-012601.md) | [22.5](/filings/0001628280-26-034130.md) | [31.5 d](/filings/0001628280-26-056919.md) |
| Dividends paid | $m | [1.1 d](/filings/0001628280-24-047429.md) | [0.0 d](/filings/0001628280-25-009626.md) | not reported | not reported | [0.0 d](/filings/0001628280-25-050298.md) | [0.0 d](/filings/0001628280-26-012601.md) | not reported | not reported | [0.0 d](/filings/0001628280-25-050298.md) | [0.0 d](/filings/0001628280-26-012601.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [5.1](/filings/0001185185-23-001183.md) | [5.3](/filings/0001185185-24-000475.md) | [0.7](/filings/0001628280-24-037059.md) | [0.7](/filings/0001628280-24-047429.md) | [0.7](/filings/0001628280-25-023834.md) | [0.7](/filings/0001628280-25-040367.md) | [359](/filings/0001628280-25-050298.md) | [451](/filings/0001628280-26-034130.md) | [565](/filings/0001628280-26-056919.md) | [715](/filings/0001628280-25-050298.md) | [744](/filings/0001628280-26-034130.md) | [767](/filings/0001628280-26-056919.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,037,490,709 at 2026-08-07, from the cover of the [10-Q filed 2026-08-14](/filings/0001628280-26-056919.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.